HALO logo
halo search icon
AFP
AFT Pharmaceuticals Ltd.

AFP · AFT Pharmaceuticals Ltd.

3.67

AUD
0.02 (0.548%)
12/10/2026 04:10:18 PM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$384.01M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

3Neutral

As at 12/10/2026 04:10:18 PM

Price Chart

Description

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

  • All-Companies
  • All-Consensus
  • GROWTH AUS
  • HALO Momentum
  • HALO Ords
  • HALO Price Momentum

Key Fundamentals

EPS 3 yr Growth

-16.70%

EBITDA Margin

11.00%

Operating Cashflow

-$10m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

Low 2.48 - 4.13

Trade Value (12mth)

AU$1,334.00

1 week

4.89%

1 month

-1.35%

YTD

22.07%

1 year

42.58%

All time high

5.25

Additional Data

Shares Outstanding (Fully Diluted)

105m

HALO Sector

Healthcare

Next Company Report Date

24-May-27

Next Ex Dividend Date

18-Jun-26

Next Dividend Pay Date

03-Jul-26

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
06 October 26ASXD
28 September 26ASXD
31 July 26ASXD
31 July 26ASXD
31 July 26ASXD

Key Stakeholders

NameTitle
Hartley AtkinsonIndividual
Hama Holdings Ltd.Private Company
Apex Group Ltd.Holding Company
Garrett Smythe Ltd.Private Company
Joeri Yvonne Jozef SelsIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The current share price of AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$3.67.
2
What is the 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$4.13.
3
What is the 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$2.48.
4
What is the dividend yield for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) does not pay a dividend.
5
What was AFT Pharmaceuticals Ltd. (AFP:ASX) last dividend payment?
Halo FAQ
The last dividend payment of AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$0.02.
6
What is the franking level for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) has a franking level of 0.00%.
7
In which sector is AFT Pharmaceuticals Ltd. (AFP:ASX) classified?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) is classified in the Healthcare.